Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia
  • Published:

Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia

Leukemia volume 14, pages 502–504 (2000)Cite this article

Abstract

The number of allogeneic transplants from unrelated donors has grown in the past decade in part because of the expansion of the donor registry size. Patient survival has improved due to the selection of more closely matched donors and the development of effective infection prophylaxis. Relapse-free survival remains limited in patients with a large tumor burden at the time of transplantation. A higher marrow cell dose is the major factor to minimize transplant-related death. Future studies of peripheral blood stem cell transplants should be considered for patients with acute leukemia with the goal of enhancing the stem cell dose and improving survival.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Horowitz MM, Rowlings PA . An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation Curr Opin Hematol 1997 4: 395–400

    Article  CAS  Google Scholar 

  2. Anonymous . Bone Marrow Donors Worldwide Internet address: http://www.bmdw.org

  3. Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C . Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose Blood 1997 89: 4226–4235

    CAS  PubMed  Google Scholar 

  4. Ringden O, Remberger M, Runde V, Bornhauser M, Blau IW, Basara N, Holig K, Beelen DW, Hagglund H, Basu O, Ehninger G, Fauser AA . Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation Blood 1999 94: 455–464

    CAS  PubMed  Google Scholar 

  5. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C . Outcome of cord-blood transplantation from related and unrelated donors New Engl J Med 1997 337: 373–381

    Article  CAS  Google Scholar 

  6. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE . Outcomes among 562 recipients ofplacental-blood transplants from unrelated donors New Engl J Med 1998 339: 1565–1577

    Article  CAS  Google Scholar 

  7. Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C, Yu M, Dunbar C, Barrett J . CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies Blood 1996 88: 3223–3229

    CAS  PubMed  Google Scholar 

  8. Wagner JE, King R, Kollman K, Anasetti C, Antin J, Casper J, Champlin R, Davies SM, Drobyski W, Fay J, Filipovich A, Heslop H, Karanes C, Kernan N, Nademanee A, Schmeckpeper B, Howe C . Unrelated donor bone marrow transplantation in 5075 patients with malignant and nonmalignant disorders: impact of marrow T cell depletion Blood 1998 92: 686a (Abstr.)

    Google Scholar 

  9. Papadopoulos EB, Carabasi MH, Castro-Malaspina H, Childs BH, Mackinnon S, Boulad F, Gillio AP, Kernan NA, Small TN, Szabolcs P, Taylor J, Yahalom J, Collins NH, Bleau SA, Black PM, Heller G, O'Reilly RJ, Young JW . T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease Blood 1998 91: 1083–1090

    CAS  PubMed  Google Scholar 

  10. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, Ruggeri L, Barbabietola G, Aristei C, Latini P, Reisner Y, Martelli MF . Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with on fully mismatched HLA haplotype New Engl J Med 1998 339: 1186–1193

    Article  CAS  Google Scholar 

  11. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C . Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia New Engl J Med 1998 338: 962–968

    Article  CAS  Google Scholar 

  12. Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM, Woolfrey AE, Hansen JA . Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient Blood 1998 92: 3515–3520

    CAS  PubMed  Google Scholar 

  13. Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoki H, Yoskida T, Kimura A, Akaza T, Kamikawaji N, Kodera Y, Takaku R . Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program New Engl J Med 1998 339: 1177–1185

    Article  CAS  Google Scholar 

  14. Anasetti C, Heimfeld S, Rowley S, Martin P, Petersdorf EW, Woolfrey A, Hansen JA . Higher CD34 cell dose is associated with improved survival after marrow transplantation from unrelated donors Blood 1999 94: (in press)

Download references

Author information

Authors and Affiliations

  1. Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA

    C Anasetti

Authors
  1. C Anasetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anasetti, C. Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia. Leukemia 14, 502–504 (2000). https://doi.org/10.1038/sj.leu.2401648

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401648

Keywords

This article is cited by

Search

Advanced search

Quick links